We offer advanced open and minimally invasive pancreatic resections including arterial and venous vascular reconstruction. Working closely with our gastroenterology, radiology, medical oncology, and radiation oncology teams we provide innovative treatment sequencing and aggressive surgical management of pancreas cancers. Drs. Nywening and Karachristos focus on this disease site.

Dr. Karachristos brings decades of expertise to the hepatobiliary disease site. We offer open and minimally invasive liver resections and vascular reconstruction. We work in close contact with our Department’s leading solid organ transplant team to arrange listing for liver transplants when needed. We offer cutting edge regional therapies such as hepatic artery infusion pumps. Drs. Nywening and Karachristos focus on this disease site.

We treat a range of peritoneal surface malignancies including colorectal, appendiceal, gastric and mesothelioma tumor types. We offer advanced regional therapies such as hyperthermic intraperitoneal chemotherapy (HIPEC). The biology of these tumors is an area of focused basic and translational research for our group. Drs. Nywening and Jacobson see patients with these types of tumors.

We work in close collaboration with our medical oncology colleagues for the care of patients with neuroendocrine tumors, ensuring that our patients get the optimal treatment sequence and disease monitoring in the long term. All such cases are discussed at our robust gastrointestinal tumor board. All our surgeons see patients with these types of tumors.

Sarcoma care requires coordination between general and orthopedic surgeons, medical oncologists, radiation oncologists, and pathologists. We offer innovative multimodality treatment for both retroperitoneal and extremity sarcomas and have extensive experience with brachytherapy radiation techniques. Drs. Nywening and Jacobson focus on this disease site and Dr. Nywening is the surgical lead of our sarcoma tumor board.

We treat all types of skin cancers including basal cell carcinoma, squamous cell carcinoma, melanoma, and Merkel cell carcinoma. We have the backing of a multidisciplinary cutaneous oncology tumor board. We are particularly experienced with skin cancers that arise in organ transplant patients related to immunosuppressive medications. Dr. Jacobson sees our cutaneous oncology patients and leads a basic/translational research program in this field.